Sign in

You're signed outSign in or to get full access.

BF

Brighthouse Financial, Inc. (BHF)·Q3 2025 Earnings Summary

Executive Summary

  • Announced definitive agreement to be acquired by Aquarian Capital for $70.00 per share in cash (~$4.1B), canceling the Q3 call; merger agreement restricts common dividends until closing while permitting preferred dividends .
  • Q3 results: Total revenues $1.816B; net income to common $453M ($7.89 diluted EPS); adjusted EPS $16.87, with adjusted EPS less notable items $4.54 driven by $709M favorable notable items from the GAAP actuarial review .
  • Capital strengthened: combined RBC ratio rose to 435–455% (upper end of 400–450% target), TAC ~$5.4B, holding company liquid assets $1.0B; company expects to remain within RBC target at year-end 2025 without capital contributions .
  • Wall Street consensus: Missed S&P Global Primary EPS ($5.03* vs actual $4.54) and revenue ($2.273B* vs actual $1.816B); merger announcement likely the primary stock reaction catalyst, while AM Best placed ratings under review with negative implications post-deal .
    Values retrieved from S&P Global.

What Went Well and What Went Wrong

What Went Well

  • Record Shield Level Annuities sales; total annuity sales $2.731B (+8% YoY, +5% QoQ); life sales $38M (strong growth YoY/QoQ). CEO: “another record quarter for sales of our flagship Shield annuity products” .
  • Capital position strengthened: estimated combined RBC ratio 435–455%, at the upper end of the target range; holding company liquid assets $1.0B .
  • GAAP actuarial review delivered favorable impact: net income benefited by $316M; adjusted earnings boosted by $709M favorable notable items tied to actuarial items/insurance adjustments .

What Went Wrong

  • Core earnings momentum modest: adjusted earnings less notable items $261M ($4.54 per share), only slightly above Q2’s $198M, reflecting lower fees and lower underwriting margin offset by higher net investment income .
  • Miss versus Street: Primary EPS and revenue missed S&P Global consensus; Q3 revenue reported at $1.816B versus consensus $2.273B*; Primary EPS 4.54 versus 5.03* .
    Values retrieved from S&P Global.
  • Elevated corporate expenses: $205M pre-tax, up YoY and sequentially, and continued pressures from underwriting margin dynamics across segments .

Financial Results

MetricQ3 2024Q2 2025Q3 2025
Total Revenues ($USD Billions)$2.018 $0.871 $1.816
Net Income to Common ($USD Millions)$150 $60 $453
Diluted EPS ($USD)$2.47 $1.02 $7.89
Adjusted EPS ($USD)$12.58 $3.43 $16.87
Adjusted EPS less notable items ($USD)$3.99 $3.43 $4.54
Adjusted Net Investment Income Yield (%)4.26% 4.28% 4.40%
Book Value per Common Share ($)$63.94 $69.57 $81.60

Segment adjusted earnings ($USD Millions):

SegmentQ3 2024Q2 2025Q3 2025
Annuities$327 $332 $304
Life$(25) $(26) $40
Run-off$463 $(83) $641
Corporate & Other$2 $(25) $(15)

Sales ($USD Millions):

SalesQ3 2024Q2 2025Q3 2025
Annuities$2,528 $2,610 $2,731
Life$30 $33 $38

Key capital & liquidity KPIs:

KPIQ3 2024Q2 2025Q3 2025
Combined RBC Ratio400%–420% 405%–425% 435%–455%
Combined TAC ($USD Billions)$5.699 $5.560 $5.400
Holdco Liquid Assets ($USD Billions)$0.9 $1.0
Wtd Avg Diluted Shares60,949,819 57,734,170 57,512,901
Book Value per Share ex-AOCI ($)$132.91 $144.09 $151.94

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Combined RBC RatioFY 2025 year-endTarget range 400%–450% in normal markets Expect to remain within 400%–450% at year-end 2025 without contributing capital to subs Maintained
Statutory ReservesFY 2025 reviewN/AAnticipate annual actuarial review will increase statutory reserves Increase expected
Common Stock DividendsInterim to closingNormal courseCompany agreed not to declare/pay common dividends until closing of merger Suspended per merger agreement
Preferred Stock DividendsInterim to closingOngoingPermitted; per-quarter maxima specified for Series A/B/C/D; preferred remain outstanding post-closing Maintained
Earnings CallQ3 2025PlannedCanceled due to announced transaction Canceled

Earnings Call Themes & Trends

TopicPrevious Mentions (Q1 & Q2 2025)Current Period (Q3 2025)Trend
Hedging strategy (VA/Shield separation)Management progressing to separate VA and first-gen Shield hedging; simplification to reduce volatility; completion targeted by Sept/Q3; emphasis on protecting statutory balance sheet “completed the separation of our legacy VA and first-generation Shield business” Progressed to implementation
Capital & RBCRBC within target (Q1: 420–440%, Q2: 405–425%); aim to remain in range; TAC movement explained via VA/Shield dynamics RBC 435–455% (upper end); expect within target at YE without capital contributions Strengthened
Sales & pricing disciplineStrong RILA (Shield) sales; fixed annuity competition; maintain pricing discipline; LPP deposits ramping Record Shield sales; total annuity sales +8% YoY; life sales +27% QoQ Positive momentum
Surrenders/flowsExpect 2025 flows at or above 2024 given products exiting surrender periods; VA/Shield outflows observed Not updated (press release only); sales growth offsets flows Ongoing watch
Share repurchases$59M Q1, $43M Q2; pause after May under 10b5-1 expiration; $441M remaining authorization No update due to merger/call cancellation Paused/quiet period
Ratings contextAM Best placed ratings under review with negative implications tied to transaction execution risks New risk overlay

Management Commentary

  • CEO: “Brighthouse Financial delivered solid results… achieving another record quarter for sales of our flagship Shield annuity products… completed the separation of our legacy VA and first-generation Shield business, and ended the quarter with an estimated combined RBC ratio of 435% to 455%, at the upper end of our target range” .
  • CEO on transaction: “We believe the transaction with Aquarian Capital… will deliver clear and compelling value to our stockholders” .
  • CFO (prior quarter context on hedging): Separation is aimed at simplification and reduced volatility without changing focus on statutory protection; rate and equity hedge profiles adjusted along the curve and delta positioning, respectively .

Q&A Highlights

  • Hedging separation and impact: Management emphasized simplification, transparency, and expected reduction in volatility; not a wholesale change; completion by Q3 with liability model updates .
  • Buybacks cadence and authorization: Historical use of 10b5‑1 plans; plan expired in May; $441M remaining authorization; cautious on forward guidance amid transaction backdrop .
  • RBC dynamics and TAC: Detailed explanation of divergence/convergence under strong markets and VA total asset requirement framework; Q2 normalized statutory losses did not materially impair RBC due to reserve/TAC interaction .
  • Cash flow projections: Long-term distributable cash flow outlook deferred until strategic/hedging initiatives complete; unlikely in 2025 .

Estimates Context

Metric (Q3 2025)ConsensusActual# of EstimatesVs Consensus
Primary EPS Consensus Mean ($)5.03*4.54 8*Miss
Revenue Consensus Mean ($USD Billions)2.273*1.816 4*Miss

Values retrieved from S&P Global.

Implications: Consensus likely needs to incorporate the sizable non-GAAP notable items, actuarial assumption changes (10-year UST mean reversion to 4.50%), and the VA/Shield separation effects on reported GAAP versus adjusted figures .

Key Takeaways for Investors

  • M&A overhang: The $70.00 cash deal sets a near-term anchor for the equity narrative; regulatory and execution risks identified by AM Best (ratings under review) should be monitored .
  • Core run-rate: Adjusted earnings less notable items ($261M; $4.54 per share) improved modestly QoQ, with mix shifts (Run-off/Life stronger, Annuities softer) and higher net investment income; traders should focus on underlying fee and underwriting margin trajectories post-hedging separation .
  • Capital strength: RBC at 435–455% and $1.0B holdco liquidity support resilience; management expects YE 2025 within target without capital contributions—reduces downside capital risk into closing .
  • Non-GAAP adjustments: The $709M favorable notable items materially inflated adjusted EPS; use adjusted less notable items for comparability and valuation signals .
  • Sales durability: Record Shield sales and solid life sales point to durable franchise demand; maintain awareness of surrender/flow dynamics into H2 due to products exiting surrender charge periods .
  • Communication cadence: No Q3 call; expect limited updates pending proxy and regulatory milestones; common dividends restricted pre-close, preferred dividends continue as specified .
  • Risk watchlist: Track actuarial/statutory reserve increases, execution of VA/Shield hedge separation in reported results, and any reinsurance or capital actions that could shape post-deal performance .